Lake Street analyst Jacob Stephan raised the firm’s price target on Cardlytics (CDLX) to $18 from $13 and keeps a Buy rating on the shares after the company announced “strong” Q4 results and guided estimates ahead of the Street. Of note, Cardlytics announced a 3-year agreement with American Express (AXP) to utilize the company’s platform and while the firm thinks the implementation with AmEx will take time, it believes this will likely be a strong contributor to growth in 2025 and beyond.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CDLX:
- Cardlytics Inc to Share Insightful Presentation for Investors
- Cardlytics Announces Fourth Quarter and Full Year 2023 Financial Results
- Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
- Cardlytics, Inc. (CDLX) Q4 Earnings Cheat Sheet
